196 related articles for article (PubMed ID: 35039472)
1. The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis.
Yang D; Xu P; Su H; Zhong W; Xu J; Su Z; Liu X
Cell Death Dis; 2022 Jan; 13(1):60. PubMed ID: 35039472
[TBL] [Abstract][Full Text] [Related]
2. Blocking the histone lysine 79 methyltransferase DOT1L alleviates renal fibrosis through inhibition of renal fibroblast activation and epithelial-mesenchymal transition.
Liu L; Zou J; Guan Y; Zhang Y; Zhang W; Zhou X; Xiong C; Tolbert E; Zhao TC; Bayliss G; Zhuang S
FASEB J; 2019 Nov; 33(11):11941-11958. PubMed ID: 31373855
[TBL] [Abstract][Full Text] [Related]
3. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer.
Yang L; Lei Q; Li L; Yang J; Dong Z; Cui H
Clin Epigenetics; 2019 Dec; 11(1):199. PubMed ID: 31888761
[TBL] [Abstract][Full Text] [Related]
4. Histone methyltransferase DOT1L mediates the TGF-β1/Smad3 signaling pathway through epigenetic modification of SYK in myocardial infarction.
Li F; Li L; Zhang J; Yang X; Liu Y
Hum Cell; 2022 Jan; 35(1):98-110. PubMed ID: 34635982
[TBL] [Abstract][Full Text] [Related]
5. A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis.
Coward WR; Feghali-Bostwick CA; Jenkins G; Knox AJ; Pang L
FASEB J; 2014 Jul; 28(7):3183-96. PubMed ID: 24652950
[TBL] [Abstract][Full Text] [Related]
6. Interplay between EZH2 and G9a Regulates CXCL10 Gene Repression in Idiopathic Pulmonary Fibrosis.
Coward WR; Brand OJ; Pasini A; Jenkins G; Knox AJ; Pang L
Am J Respir Cell Mol Biol; 2018 Apr; 58(4):449-460. PubMed ID: 29053336
[TBL] [Abstract][Full Text] [Related]
7. Nullifying epigenetic writer DOT1L attenuates neointimal hyperplasia.
Huang Y; Urabe G; Zhang M; Li J; Ozer HG; Wang B; Kent KC; Guo LW
Atherosclerosis; 2020 Sep; 308():22-31. PubMed ID: 32799103
[TBL] [Abstract][Full Text] [Related]
8. The disruptor of telomeric silencing 1-like (DOT1L) promotes peritoneal fibrosis through the upregulation and activation of protein tyrosine kinases.
Tao M; Shi Y; Chen H; Li J; Wang Y; Ma X; Du L; Wang Y; Yang X; Hu Y; Zhou X; Zhong Q; Yan D; Qiu A; Zhuang S; Liu N
Mol Biomed; 2024 Jan; 5(1):3. PubMed ID: 38172378
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the cardiac fibroblast-enriched histone methyltransferase Dot1L prevents cardiac fibrosis and cardiac dysfunction.
Xu J; Wang J; Long F; Zhong W; Su H; Su Z; Liu X
Cell Biosci; 2022 Aug; 12(1):134. PubMed ID: 35986422
[TBL] [Abstract][Full Text] [Related]
10. Loss of Histone H3 K79 Methyltransferase Dot1l Facilitates Kidney Fibrosis by Upregulating Endothelin 1 through Histone Deacetylase 2.
Zhang L; Chen L; Gao C; Chen E; Lightle AR; Foulke L; Zhao B; Higgins PJ; Zhang W
J Am Soc Nephrol; 2020 Feb; 31(2):337-349. PubMed ID: 31843983
[TBL] [Abstract][Full Text] [Related]
11. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
12. CBX5/G9a/H3K9me-mediated gene repression is essential to fibroblast activation during lung fibrosis.
Ligresti G; Caporarello N; Meridew JA; Jones DL; Tan Q; Choi KM; Haak AJ; Aravamudhan A; Roden AC; Prakash YS; Lomberk G; Urrutia RA; Tschumperlin DJ
JCI Insight; 2019 May; 5(12):. PubMed ID: 31095524
[TBL] [Abstract][Full Text] [Related]
13. Histone Methyltransferase Dot1L Contributes to RIPK1 Kinase-Dependent Apoptosis in Cerebral Ischemia/Reperfusion.
Wang J; Zhong W; Su H; Xu J; Yang D; Liu X; Zhu YZ
J Am Heart Assoc; 2021 Dec; 10(23):e022791. PubMed ID: 34796721
[TBL] [Abstract][Full Text] [Related]
14. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of miR-182-5p attenuates pulmonary fibrosis via TGF-β/Smad pathway.
Chen Y; Zhang Q; Zhou Y; Yang Z; Tan M
Hum Exp Toxicol; 2020 May; 39(5):683-695. PubMed ID: 31884830
[TBL] [Abstract][Full Text] [Related]
16. DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.
Chen CW; Koche RP; Sinha AU; Deshpande AJ; Zhu N; Eng R; Doench JG; Xu H; Chu SH; Qi J; Wang X; Delaney C; Bernt KM; Root DE; Hahn WC; Bradner JE; Armstrong SA
Nat Med; 2015 Apr; 21(4):335-43. PubMed ID: 25822366
[TBL] [Abstract][Full Text] [Related]
17. PGC1α repression in IPF fibroblasts drives a pathologic metabolic, secretory and fibrogenic state.
Caporarello N; Meridew JA; Jones DL; Tan Q; Haak AJ; Choi KM; Manlove LJ; Prakash YS; Tschumperlin DJ; Ligresti G
Thorax; 2019 Aug; 74(8):749-760. PubMed ID: 31182654
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of microRNA-9 reduces inflammatory response and fibroblast proliferation in mice with idiopathic pulmonary fibrosis through the ANO1-mediated TGF-β-Smad3 pathway.
Dai WJ; Qiu J; Sun J; Ma CL; Huang N; Jiang Y; Zeng J; Ren BC; Li WC; Li YH
J Cell Physiol; 2019 Mar; 234(3):2552-2565. PubMed ID: 30144053
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Disruptor of Telomeric Silencing 1-Like Alleviated Renal Ischemia and Reperfusion Injury-Induced Fibrosis by Blocking PI3K/AKT-Mediated Oxidative Stress.
Yang C; Chen Z; Yu H; Liu X
Drug Des Devel Ther; 2019; 13():4375-4387. PubMed ID: 31920287
[TBL] [Abstract][Full Text] [Related]
20. The role of DOT1L in the proliferation and prognosis of gastric cancer.
Song Z; Wei Z; Wang Q; Zhang X; Tao X; Wu N; Liu X; Qian J
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31939604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
